Consistent to our previous studies on colon and pancreatic cancer, here we demonstrate again that the high level of COX-2 in breast cancer cells can be capitalized on inhibiting cancer growth and migration. This evidence concerns the gene PTGS2 and familial pancreatic carcinoma.